Literature DB >> 10463904

Contribution of randomised controlled trials to understanding and management of early breast cancer.

M Baum1, J Houghton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463904      PMCID: PMC1116442          DOI: 10.1136/bmj.319.7209.568

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  29 in total

Review 1.  Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies.

Authors:  E P Mamounas
Journal:  Semin Oncol       Date:  1998-04       Impact factor: 4.929

2.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.

Authors:  J Ragaz; S M Jackson; N Le; I H Plenderleith; J J Spinelli; V E Basco; K S Wilson; M A Knowling; C M Coppin; M Paradis; A J Coldman; I A Olivotto
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

3.  Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

4.  Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1996-11-06       Impact factor: 13.506

5.  Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial.

Authors:  B Fisher; E Montague; C Redmond; B Barton; D Borland; E R Fisher; M Deutsch; G Schwarz; R Margolese; W Donegan; H Volk; C Konvolinka; B Gardner; I Cohn; G Lesnick; A B Cruz; W Lawrence; T Nealon; H Butcher; R Lawton
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

6.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

7.  Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1996-12-18       Impact factor: 13.506

8.  Treatment of early breast cancer: a report after ten years of a clinical trial.

Authors:  H Atkins; J L Hayward; D J Klugman; A B Wayte
Journal:  Br Med J       Date:  1972-05-20

9.  Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes.

Authors:  M J Harper; A L Walpole
Journal:  Nature       Date:  1966-10-01       Impact factor: 49.962

10.  Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-09-19       Impact factor: 79.321

View more
  4 in total

1.  Clinical trial results applied to management of the individual cancer patient.

Authors:  Ismail Jatoi; Michael A Proschan
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Patient and clinician collaboration in the design of a national randomized breast cancer trial.

Authors:  Jo Marsden; Jane Bradburn
Journal:  Health Expect       Date:  2004-03       Impact factor: 3.377

3.  Predicted trends in long-term breast cancer survival in England and Wales.

Authors:  L M Woods; B Rachet; N Cooper; M P Coleman
Journal:  Br J Cancer       Date:  2007-04-10       Impact factor: 7.640

4.  How often does an individual trial agree with its corresponding meta-analysis? A meta-epidemiologic study.

Authors:  Wilson W S Tam; Jin-Ling Tang; Meng-yang Di; Kelvin K F Tsoi
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.